Qlife wins US patent approval for core Egoo platform technology
Qlife Holding AB secured U.S. patent approval for core technology behind its Egoo decentralized biomarker-testing platform. Coverage targets the underlying platform architecture, including integrated sample mixing and optical measurement in a compact, automated system. Management framed the U.S. intellectual-property p